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Implication for health policy/practice/research/medical education:
The prevalence and clinical picture of  IgA nephropathy (IgAN) varies from region to region. There is a limited knowledge 
about the morphological features of  this disease according to recent Oxford-MEST classiﬁcation in Iran and Middle East.
In this study higher prevalence of  segmental glomerulosclerosis and interstitial ﬁbrosis/tubular atrophy as the two of  four 
variables of  this classiﬁcation in male patients further attests that male gender is a risk factor in this kind of  disease. Signiﬁcant 
correlation between serum creatinine and extracapillary proliferation was in an agreement with previous studies and was sug-
gested for  the probable accommodation of  crescent as a new variable in the MEST system.
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ABSTRACT
Background: There is a limited knowledge about the morphological features of  IgA 
nephropathy (IgAN)in the middle east region. 
Objectives: The objective of  this study was to evaluate the spectrum of  histopatho-
logical ﬁndings  in IgAN patients at our  laboratory.
Patients and Methods: At this work, an observational study reported which was con-
ducted on IgAN patients using the Oxford-MEST classiﬁcation system.
Results: In this survey, of  102 patients 71.6 % were male. The mean  age of  the 
patients was 37.7 ± 13.6 years. Morphologic variables of  MEST classiﬁcation was 
as follows; M1: 90.2 %, E: 32 %, S: 67 % also,T in grads I and II  were in 30% and 
19% respectively, while 51% were in grade zero. A signiﬁcant difference was ob-
served in segmental glomerulosclerosis (P=0.003) and interstitial ﬁbrosis/tubular 
atrophy frequency distribution (P= 0.045), between  males and females . Further-
more, it was found that mesangial hypercellularity was more prevalent in yonger 
patients. Moreover, there was a signiﬁcant correlation between serum creatinine 
and  crescents (P<0.001). There was also signiﬁcant correlation of  serum creatinine 
with  segmental glomerulosclerosis (P<0.001). 
Conclusions: Higher prevalence of  segmental glomerulosclerosis and interstitial ﬁbro-
sis/ tubular atrophy, as the two of, four variables of  Oxford-MEST classiﬁcation of  
IgAN in male patients further attests that male gender is a risk factor in this disease.
In this study the signiﬁcant correlation between serum creatinine  and  crescent was 
in an agreement with previous studies and suggests for the probable accomodation 
of  extracapillary proliferation as a new variable in  MEST system.
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1. Background
 gA nephropathy (IgAN) was ﬁrst described by 
Berger (1, 2) and is the most common type of  
glomerulonephritis worldwide (2-5). Its prev-
alence varies across the world, ranging from less 
than 10% in United States to 30-40% in Asia (2-6) 
and   around  40% of   patients progress to end-
stage renal disease (ESRD) after 20 years (3-5). 
 IgAN is a disease of  young males and com-
monly presents itself  with episodic macroscopic 
and microscopic hematuria or with kidney failure 
and hypertension (3-7). There is no doubt that 
IgA nephropathy is an extremely common disease 
(5-8). Indeed, IgAN is the main cause of  ESRD in 
patients of  all ages with primary glomerular disease 
(4-9). Its diagnosis was based on the histopatho-
logic and immunohistochemical evaluation of  re-
nal biopsy (4). By light microscopy, the glomeruli 
may show various morphologic manifestations 
of  immune complex glomerulonephritis from 
normal to severe crescentic glomerulonephritis 
through mesangial proliferation, endocapillary 
proliferation and tuft necrosis (10-15). By immu-
nohistochemistry, IgA is the sole immunoglobulin 
in 26% of  biopsies; around 25% have IgA, IgG 
and IgM. Also C3 presents in 95% (10-20) of  the 
cases. C1q if  presents only in trace amounts in 
biopsies and if  prominent should raise the pos-
sibility of  systemic lupus erythematosus(10-20). 
Segmental proliferation and segmental scars are 
also common (10-17) and usuallyglomerular scars 
are associated with tubular atrophy and interstitial 
ﬁbrosis (10-18). The wide variety of  clinical and 
histopathologic presentations of  IgAN, indicate 
the utility of  the proposed histologic classiﬁcation 
to asses patient’s likelihood of  developing ESRD 
(15-17, 20). 
 Indeed there has been a lack of  internation-
al consensus on the classiﬁcation and the pre-
dictive value of  the histopathology ﬁndings in 
IgAN. Previously Lee and Haas, have published 
a classiﬁcations method for IgAN (15-20). The 
recent Oxford classiﬁcation of  IgAN assesses 
the presence of  hypercellularity, proliferation in 
mesangial and endocapillary regions, segmental 
glomerulosclerosis and tubular atrophy/intersti-
tial (MEST).Also it has been reported as having 
prognostic value (14, 21-24). This classiﬁcation 
method looked for reproducible pathological fea-
tures that were correlated to renal survival inde-
pendent of   clinical features, rather than group-
ing patients into categories (24).
2. Objectives
 The prevalence and clinical picture of  IgAN 
varies from region to region.This study was un-
dertaken, ﬁrstly to study the morphologic chang-
es in a group of  IgAN patients, to assess the 
Oxford classiﬁcation method and other morpho-
logic variables, and secondly to compare patho-
logical ﬁndings with published studies. 
3. Patients and Methods
 After publication of  Oxford classiﬁcation of  
IgAN on 1 July 2009 (25-27),  we applied it in this 
study for the classiﬁcation of  IgAN.
3.1. Deﬁnition of  IgAN 
 The pathologic diagnosis of  IgAN requires 
the demonstration of  IgA-dominant mesangial 
or mesangio-capillary immune deposits through 
immune ﬂuorescence (IF) microscopy. The im-
mune deposits were semiquantitied from 0 to 3+ 
positive bright. The deﬁnition of  IgAN needs  the 
presence of  diffuse and global IgA deposits that 
were graded ≥ 2+ and the absence of  C1q de-
position (3, 27-29). All renal biopsies performed 
at various medical centers (university hospitals or 
private centers) from July 2009 to February 2012, 
were sent to a reference laboratory. Except for 
two Afghan patients, the rest of  cases were Ira-
nian. None of  the patients was treated before the 
biopsy. In one hundred  ten (110) biopsies, prom-
inent IgA depositis were observed on IF study. 
I
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Of  110 biopsies with dominant IgA deposition, 
one was due to  a kidney transplantation (reccur-
rence of  IgAN), one patient with diagnosis of  
Henoch Schonelin purpura , two of  the patients 
with the dominant IgA deposits in association 
with concurrent diabetes mellitus and one patient 
with IgAN, whose biopsy had been taken from 
medulla  for light microscopy (without glomer-
ules), which  were excluded from the study.Biop-
sies with less than 8 glomeroli were also excluded 
from the study.Two of  the patients underwent 
re-biopsy, due to absence of  glomeruli for IF 
or light microscopic study. None of  the patients 
was diagnosed as IgAN,  having history of  col-
lagen vascular diseases and liver cirrhosis based 
on questionaire ﬁlled at the time of  biopsy ad-
mission, laboratory data in patients’ records and 
a breif  history provided by referee physicians at 
the time of  biopsy admission.
 3.2. Histologic data
 All renal biopsies were prepared for light  and 
direct immunoﬂuorescence microscopy. Tissue 
was ﬁxed in 10% formalin for histologic section-
ing. Each kidney biopsy was prepared by cutting 
parafﬁn blocks into 3-μm sections and staining 2 
slides with periodic acid Schiff, 2 slides for hema-
toxylin and eosin, 1 slide for Jones methenamine 
silver and 1 slide for trichrome. Each slide con-
tained 2-3 sections. Materials usedfor IF was snap-
frozen in liquid nitrogen. Sections (Six-micron in 
thickness) were stained for immunoﬂuorescence 
study with ﬂuorescein isothiocyanate-conjugated 
antibodies speciﬁc for human IgG, IgM, IgA, C1q, 
C3 and  ﬁbrin (DAKO, Produktionsvej 42, DK-
2600 Glostrup, Denmark). IF slides were reported 
in a scale of  0, to 3+ positive bright. IF slides were 
reported by a nephropathologist (HN) and a gen-
eral pathologist (SB). IF study was performed un-
aware of  patients’ data and before reviewing the 
slides for light microscopy. After IF diagnosis of  
IgAN, histopathology glass slides were reviewed 
to assess the morphologic variables, which were 
applied in Oxford-MEST classiﬁcation method. 
Other important pathology ﬁndings were also 
assessed including glomerular ﬁbrinoid necrosis, 
extracapillary proliferation (cellular, ﬁbro-cellular 
or ﬁbrous crescents), mesansial interposition and 
mesangiolysis. Also, the presence of  foamy cells 
and tubular thyroidization in interestitium were 
assessed. Vascular lesions were scored and atten-
tion was made toward the presence of  throm-
botic microangiopathy in cases. After selection 
of  biopsies having dominant deposition IgA by 
IF study and in the absence of  exclusion criteria, 
glass slides were independently reported for the 
classiﬁcation of  Oxford-MEST. Each reviewer 
completed a score sheet for every biopsy and 
these were used to compile the pathological data 
set. If  there were any differences among the score 
sheets, the histologic sections would be reviewed 
concurrently by them at a two headed microscope 
and the discrepancy reconciled. Therefore, a con-
sensus was established to conﬁrm each parameter.
3.3. Deﬁnitions of  pathological variables
 Total glomeruli and the number of  glomeruli 
with global sclerosis were recorded for each biop-
sy. The presence of  (i) mesangialhypercellularity, 
(ii) endocapillary proliferation, (iii) segmental glo-
merulosclerosis and (iv) the proportion of  tubu-
lar atrophy and interstitial ﬁbrosis were estimated 
as follows (25-27);
Mesangial hypercellularity
Present in ≤ 50% of  the glomeruli: M0
Present in > 50% of  the glomeruli: M1
Segmental glomerulosclerosis
Absent: S0
Present: S1
Endocapillary hypercellularity
Absent: E0
Present: E1
Tubular atrophy/interstitial ﬁbrosis 
0 – 25% of  cortical area:  T0
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26 – 50% of  cortical area: T1
> 50% of  cortical area: T2
3.4. Vascular deﬁnitions
 Arterial lesions are scored based on the most 
severe lesions. Intimal thickening is scored by 
comparing the thickness of  the intima to that of  
the media in the same segment of  vessel. Intima 
is scored variously as as normal (score: 0), and 
thickened to more or less than the thickness of  
the media (score: 1). Arteriolar hyaline is noted as 
the proportion of  arterioles affected and is scored 
according to the following categorization; normal 
arterioles (score: 0), 1–25% affected arterioles 
(score: 1), 26–50% affected arterioles (score: 2) 
and>50% affected arterioles (score: 3) (25).
3.5. Clinical Studies and Laboratory Data
 The medical records of  patients were re-
viewed to obtain various demographic, clinical 
and laboratory information at the time of  biopsy 
and for follow-up activities. Data gathered at the 
time of  biopsy included race, gender, age, serum 
creatinine(Cr) and proteinuria (based on a 24hour 
urine collection). 
3.6. Statistical analysis
  Mean values and standard deviations were 
calculated, and statistical signiﬁcance of  the dif-
ferences between groups were calculated using T, 
Chi-square and Likelihood Ratio tests. Because of  
high positive skewness of  data, the Spearman’s co-
efﬁcient of  correlation was used to check the cor-
relation. A computer program (SPSS version 16.0, 
Chicago, IL, USA) was used for statistical analysis. 
P < 0.05 was considered statistically signiﬁcant.
4. Results
4.1. Population Characteristics
  This is an observational study, conducted on 
IgAN patients. A total of  102  biopsies were en-
rolled to the study.
4.2. Prevalence
  In this survey, of  102 patients 71.6 % were 
male, 2 % were below 20 years, 60.8 % were be-
tween 20-40 years and 37.2 % were  more than 40 
years of  age. The age of  patients was from 18 to 
73 years with mean of  37.7 ± 13.6 years (medain: 
35 years). Mean±SD of  proteinuria and serum 
creatinine were 1795 ± 1369 mg/day and 1.651 
± 1.61 mg/dL, respectively. The medain level of  
proteinuria and serum creatinine were 1500 mg/
day and 1.2 mg/dL respectively. The  mean se-
rum creatinine in females was 1.14±0.73 mg/dL 
and  in males was 1.85±1.80 mg/dL. Nephrotic 
range proteinuria  was  in 8.8% of  patients, all of  
which were male. Also, the mean of  proteinuria 
were 1323±735 mg/day and 1982±1515 mg/
day,in females and males repectively.
 After stratiﬁcation of  patients according to 
their proteinuria, we found that, 23.5% of  the pa-
tients had proteinuria below 1 g/day, 65.7% had 
proteinuria between 1-3 g/day and 10.8% of  the 
patients had proteinuria more than 3 g/day.
 In this study, of  total 15 ± 7.3 glomeruli (medi-
an=14 glomeruli) in all biopsies, 2.5 ± 3 were total-
ly sclerotic (median=2 glomeruli) and 0.46±1.11 
of  them were crescentic. In general, extracapillary 
proliferation occurred in 23 % of  the patients and 
types of  crescents were as follows; cellular cres-
cent in 10.8%, ﬁbro-cellular crescent in 7.8%  and 
ﬁbrous crescents  in 8.8% of  biopsies.
4.3. Oxford classiﬁcation (MEST)
 Four variables of  Oxford classiﬁcation were 
analyzed in our patients;
 M1; we found , 66% of  the patients with mesan-
gial hypercellularity in >50% of  glomeruli. How-
ever, mesangial hypercellularity occurred in 90.2% 
of  cases, similarly mesangial widening in 92.2% of  
patient was observed. Also The mean (SD) age of  
all patients whohad M0  and M1  was 42.27 ± 14.09 
and 35.10 ± 12.69 years respectively. 
 E1; endocapillary lesions; were found in 32 % 
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of   patients. 
 S1; segmental glomerulosclerosis whichin-
cludes mesangial sclerosis with capsular adhesions 
occurred in 67 % of  the patients. However simple 
tuft-capsule adhesion, without mesangial sclero-
sis, was observedin 61% of  patients. The percent-
age of  segmental glomerulosclerosis  were 41.1% 
and 72.6 %, in females and males respectively.
 T; tubular atrophy/interstitial ﬁbrosis (scores I 
and II) were 30% and 19% respectively, while 51% 
showed zero score. Furthermore, mean (SD) per-
cent of  interstitial ﬁbrosis was 14.6 ±  21.1% with 
a median of  5%. T1 and T2  in  females were as 
follows; 17.2% and 13.8% , while these frequen-
cies  were 37% and 20.5% for males, respectively.
4.4. Vascular lesions
 Score I of  intimal thickening of  interlobular 
arteries was 55.9%, while zero score was observed 
in 44.1% of  the patients. Scores of  arteriolar hya-
line were as follows; score I and II in 31.4 % and 
24.5%, respectively. Also, score 0 was observed in 
44.1 % of  the patients. We also found thrombotic 
microangiopathy in 2% of  our patients. 
4.5. Other lesions
 Glomerular ﬁbrinoid necrosis were present 
in 6.9% of  the patients. Mesangial interposition 
and mesangiolysis each occurred in 1% of  the pa-
tients, respectively. Foamy cells and tubular thy-
roidization of  the interstitial area were found in 
3.9% and 11.8% of  patients, respectively. 
4.6. Gender and group differences
 The independent samples t-test showed a 
higher serum creatinine (P=0.044) and proteinuria 
(P=0.028) in males. The Chi-square test showed 
signiﬁcant difference in segmental glomeruloscle-
rosis between males and females with higher val-
ues in male geneder (P= 0.003). The Likelihood 
Ratio test showed signiﬁcant differences in fre-
quency distribution of  interstitial ﬁbrosis/tubular 
atrophy in males and females, with higher values 
in male geneder (P= 0.045). Also, M1 was more 
prevalent  in younger patients (P= 0.01).
4.7. Correlations
 In this study, there was a signiﬁcant correla-
tion between serum Cr and total crescents (Spear-
man’s rho = 0.386, P<0.001) (ﬁg.1).
 In this study there was also a signiﬁcant 
correlation between serum Cr and segmental 
glomerulosclerosis (Spearman’s rho = 0.521, 
P<0.001) (ﬁg.2).
Figure 1: Scatter plot of total crescent based on serum  creatinine
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5. Discussion
      Oxford classiﬁcation of  IgA nephropathy is 
identiﬁed by four histological features, mesangial 
cellularity, endocapillary proliferation, segmental 
sclerosis and tubular atrophy/interstitial ﬁbrosis, 
which are the independent predictors of  clinical 
outcome  (25-27, 30-34).  
 In the present study, mesangial proliferation 
and mesangial widening were observed in 90.2% 
and 92.2%, respectively. However only 66% of  
biopsies  showed score M1, while M1 was more 
prevalent in younger patients. Furthermore, 
variables of  E1 and S1were found in 32% and 
67% of  patients, respectively. In our survey, of  
102 patients, 71.6 % were male, and mean age 
of  patients was 37.7 ± 13.6 years. This ﬁnding is 
comparable with ﬁndings in a study conducted 
by Mittal et al. in India in which 66 patients with 
IgAN were identiﬁed. The mean age of  their pa-
tients was 29.9 years with a male: female ratio of  
4.4:1. They found that, most patients presented 
with renal failure and a signiﬁcant percentage 
(23%) also had nephrotic range proteinuria (35). 
This ﬁnding is in contrast to our results because 
in our study, the mean of  proteinuria and serum 
creatinine were 1795 ± 1369 mg/day and 1.651 ± 
1.61 mg/dL, respectively. Also, nephrotic range 
proteinuria  was  observed  in 8.8% of   patients. 
Study of   Mittal et al.,  showed advanced disease 
in much younger individuals (35), which  was not 
supported by our study. Khawajah et al. studied 
a total of  42 patients, who were diagnosed to 
have primary IgAN in Saudi Arabia. Majority of  
the study cases were males, in the second, third 
and fourth decades of  life. There were varying 
degrees of  mesangial proliferation (36). To an-
alyze the ﬁndings of  343 patients with IgAN, 
Maixnerova et al. have assessed the main demo-
graphic, clinical and histological data (37). Simi-
larly, they found that, male gender is predominat-
ed over female gender. The median age of  IgAN 
patients was 32.3 years, and the median level of  
proteinuria was 1.8 g/day. These ﬁndings were in 
agreement with our study,  in which patients had 
a median age of  35 years and median proteinuria 
of  1.5g/day. To clarify the prognostic factors and 
the renal survival rates of  223 patients with IgAN, 
Kang et al. found that glomerular sclerosis,  is a 
risk factor for developing ESRD.  We also found 
a signiﬁcant correlation between serum  Cr and 
segmental glomerulosclerosis, a ﬁnding which 
correlates with Kang’s study. To ﬁnd the rela-
tionship of  four variables applied in the MEST 
classiﬁcation with the outcome of  the disease, 
Grcevska et al., conducted a study in 40 adult 
patients with IgAN. They found that mesangial 
Figure 2: Scatter plot of segmental glomerulosclerosis based on serum creatinine
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hypercellularity, glomerular sclerosis, endocapil-
lary hypercellularity and IFTA were associated 
with the renal outcome likelihood ratio (22). To 
evaluate the predictive value of  the Oxford clas-
siﬁcation on renal survival deﬁned by doubling 
creatinine or end-stage renal disease in patients 
with IgA nephropathy, 183 patients with IgA ne-
phropathy  were investigeted by Alamartine et al., 
in France. They found that tubular atrophy/inter-
stitial ﬁbrosis, segmental glomerulosclerosis, and 
endocapillary hypercellularity strongly impacted 
doubling creatinine or end-stage renal disease. On 
the contrary, mesangial hypercellularity was not 
associated with renal outcome. They concluded 
that the baseline renal function seems to be of  a 
greater importance than pathologic lesions (38). 
Shi et al., studiedthe Likelihood Ratio of  410 pa-
tients with IgAN, from China. They evaluated 
the predictive value of  the Oxford classiﬁcation 
and found that tubular atrophy and interstitial 
ﬁbrosis  are  the independent predictive factors 
of  ESRD. Patients who had >25% of  glomeruli 
with endocapillary hypercellularity showed high-
er proteinuria, lower glomerular ﬁltration rate 
and higher mean arterial pressure (MAP) than 
patients with less endocapillary hypercellularity 
(39). Similarly data obtained from 146 cases  with 
biopsy proven IgAN were analyzed by Walsh et 
al., from Canada. Their data revealed that >40% 
glomerular sclerosis and a systolic blood pres-
sure>150 mmHg were risk thresholds. Moreover, 
they found that baseline creatinine, proteinuria, 
systolic blood pressure, glomerular sclerosis, in-
terstitial ﬁbrosis and crescentic disease were the 
predictors of  primary outcome (40). Further-
more, they showed that interstitial ﬁbrosis, glo-
merular sclerosis  and crescents remained as the 
independent predictors of   primary outcome 
and signiﬁcantly improved model ﬁt compared 
to clinical characteristics alone. They concluded 
that baseline histopathologic parameters are the 
predictors of  adverse outcomes in IgAN even 
after taking into consideration clinical character-
istics. Also, relatively small degrees of  interstitial 
ﬁbrosis confer an increased risk for progressive 
IgAN (40). In a study conducted by El Karoui et 
al.,  on 128 IgAN cases  with mean age of  38.7 
years (range18–78) in France , they found  that 
mean proteinuria was 2.43 g/day(33), while we 
found  1795 ± 1369 mg/day proteinuria in our 
cases.The medain level of  proteinuria  in our pa-
tients was 1.5g/day, implies that patients studied 
by El Karoui et al., were more proteinuric. We 
also found that nephrotic range proteinuria was 
observed in 8.8% of  our patients, where all were 
male. Similarly, the age of  our patients was rang-
ing from 18 to 73 years with a mean of  37.7 ± 
13.6 years.
     Except of  four variables of  MEST system, 
there was a concern, whether other pathology 
variables in the glomeruli, interstitial or vessels 
may have prognostic outcome. Among them, 
more importantly, however, is extracapillary pro-
liferation.Indeed, this classiﬁcation is entirely 
limited to four above mentioned morphological 
features (19) and  did not include crescent  in the 
analysis (25-27, 29, 31).Likewise, there are other 
pathology variables, which may  be associated 
with the renal outcome and need further atten-
tion. These are  IF and electron microscopic ﬁnd-
ings, which  were not included  in  this classiﬁca-
tion (19). Various studies, however, showed that 
crescentic disease is a predictor of  the primary 
outcome and had been reported as one of  the 
most important prognosticators in IgAN (15, 28, 
41). In our study, extracapillary proliferation oc-
curred in 23% of  patients, which was lower than 
what had been observed in the Oxford study 
(45%). This lower percentage of  extracapillary 
proliferation was also found in the study con-
ducted by El Karoui et al., in pares. They found 
that extracapillary proliferation occurs in 31 
(24.2%) out of   128 IgAN cases, while mean age 
of  their patients was similar to ours (33).Likewise, 
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Bitencourt-Dias et al., analyzed  144 patients with 
IgAN. Crescents were found in 18% of   their pa-
tients. They concluded that the presence of  cres-
cents was associated with higher levels of  initial 
serum creatinine and urinary protein excretion 
and a higher frequency of  hypertension and pro-
gression to end-stage renal disease(42). Simiraly 
we found a signiﬁcant correlation between se-
rum Cr and total crescents. Edström Halling et 
al., investigeted ninety-nine children with IgAN 
and showed that mesangial hypercellullarity score 
>0.5, presence of  endocapillary hypercellularity 
or IFTA of  >25% were each associated with a 
poor outcome. They found that three of  the four 
histology lesions identiﬁed in the Oxford classiﬁ-
cation, as well as the presence of  crescents, were 
valid in predicting a poor outcome in their patient 
(10, 43, 44). Similarly, Katafuchi et al., conducted 
a study on the likelihood ratio of  702 patients 
with IgAN. They suggested  extracapillary pro-
liferation to be included in the next version of  
the Oxford classiﬁcation of  IgAN to widen the 
scope of  classiﬁcation (31). Hence, it seems that 
data on prognostic signiﬁcance of   extracapillary 
proliferation,as a variable which need to accom-
modate on MEST, is increasing.
     Thrombotic microangiopathy (TMA) occurs 
in IgA nephropathy, but is uncommon in the set-
ting of  IgA nephropathy and its signiﬁcance, as a 
concomitant histologic ﬁnding, is unclear (45). In 
a study on 10 patients with an established diagno-
sis of  IgA nephropathy and concurrent ﬁndings 
of  TMA, based on their renal biopsies, Chang et 
al., found six patients presented with malignant 
hypertension, while three others had severe hy-
pertension and ﬁve patients had nephrotic-range 
proteinuria (45). They also found that seven pa-
tients had occasional arteriolar thrombi identiﬁed 
by light microscopy and prominent glomerular 
subendothelial space widening by electron mi-
croscopy, while three patients demonstrated only 
ultrastructural features of  thrombotic microangi-
opathy. They suggested that a thrombotic micro-
angiopathy injury, when present, is usually found 
in advanced stages of  IgA nephropathy and can 
be associated with severe proteinuria (45). In our 
study, of  102 patients with IgAN, 2% of  them 
were found to have TMA, while all of  them had 
malignant hypertension. In contrast, a high fre-
quency of  thrombotic microangiopathy (TMA) 
was observed by some investigators in the cases 
of  IgAN. El Karoui et al., retrospectively exam-
ined a series of  128 patients diagnosed with IgA 
nephropathy in France. In their series, 53% pre-
sented with lesions of  TMA, acute or organized, 
in arteries and/or arterioles. Among patients with 
TMA, 4% were normotensive, 25% had con-
trolled hypertension, and 71% had uncontrolled 
hypertension. Of  those with uncontrolled hyper-
tension, 26% had malignant hypertension (46). 
Histologically, the group with TMA had a signiﬁ-
cantly greater percentage of  sclerotic glomeruli 
and worse tubulointerstitial ﬁbrosis than those 
of  the group without TMA. However, a signiﬁ-
cant minority of  patients had near-normal histol-
ogy, with minimal tubular atrophy (20%) and/
or <20% interstitial ﬁbrosis (24%). Their study 
showed that, TMA rarely occurs in the absence 
of  signiﬁcant proteinuria. They concluded that 
lesions of  TMA are frequent in IgA nephropa-
thy and may occur in normotensive patients with 
near-normal renal histology. However, this needs 
further investigation regarding its association 
with IgAN and its prognostic value. Their studies 
rule out severe hypertension or advanced renal 
disease as the sole causes of  TMA (46).
6. Conclusions
 Higher prevalence of  segmental glomerulo-
sclerosis and interstitial ﬁbrosis/tubular atrophy, 
as the two of  four variables of  Oxford-MEST 
classiﬁcation in male patients with IgAN, fur-
ther attests that male gender is a risk factor in 
this disease. Signiﬁcant correlation between se-
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rum creatinine and crescent in this study, was in 
an agreement with previous studies and suggests 
the probable accomodation of  crescent as a new 
variable in the MEST system.
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